Liver Cancer a Big Threat to U.S., Other Developed Nations
Title: Liver Cancer a Big Threat to U.S., Other Developed NationsCategory: Health NewsCreated: 6/15/2018 12:00:00 AMLast Editorial Review: 6/15/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 15, 2018 Category: Cancer & Oncology Source Type: news

Ultrasound links meat allergen to heart disease
Using intravascular ultrasound, researchers from the U.S. National Institutes...Read more on AuntMinnie.comRelated Reading: PET may help spot protein clumps in heart disease 3D printing bolsters care for congenital heart disease ACC: PET/CT calcium scans could foretell cardiac events Breast cancer treatments may boost heart disease risk Report: Trump's calcium score indicates heart disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 15, 2018 Category: Radiology Source Type: news

Medical News Today: Low vitamin D levels may raise bowel cancer risk
Pooling data from three continents and multiple studies, researchers find a link between lower vitamin D levels and increased risk of colorectal cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 15, 2018 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news

Prostate cancer symptoms: Look out for this warning sign when you go to the toilet
PROSTATE cancer symptoms don ’t often become apparent until the cancer has grown large enough to put pressure on the urethra. Many men diagnosed with this cancer won’t show signs at all, but when they do they’re usually linked to urination. If this happens when you go to the toilet it could indicate you have the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - June 15, 2018 Category: Consumer Health News Source Type: news

Time Is Up for PD-L1 Testing Standardization in Lung Cancer Time Is Up for PD-L1 Testing Standardization in Lung Cancer
Rapid efforts are needed to determine analytical concordance between PD-L1 assays.Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Laser-sonic scanner aims to replace mammograms for finding breast cancer
(California Institute of Technology) Lihong Wang, Caltech's Bren Professor of Medical Engineering and Electrical Engineering, has developed a laser-sonic scanning system that can identify breast tumors quickly and safely. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

Protein analysis may reveal new cancer treatment targets
(Wiley) Researchers have used lab technology called mass spectrometry to study the proteins expressed by human cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

20 years of excellence in gastrointestinal research and practice [WCGI 2018]
(European Society for Medical Oncology) Groundbreaking research will be revealed at this year's ESMO World Congress on Gastrointestinal Cancer (June 20-23, 2018, Barcelona, Spain), celebrating 20 years of clinical progress in a group of diseases that affect both men and women worldwide. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

No difference in malignancy rates seen between tocilizumab and TNFi in patients with RA
(European League Against Rheumatism) The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2018) examined rates of malignancy in patients with rheumatoid arthritis (RA), excluding non-melanoma skin cancer (NMSC), and found no difference between those newly treated with tocilizumab (TCZ) versus TNF inhibitors (TNFi). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

Greater levels of vitamin D associated with decreasing risk of breast cancer
(University of California - San Diego) Researchers at University of California San Diego School of Medicine suggest higher levels of vitamin D are associated with decreasing risk of breast cancer. Their epidemiological study is published in the June 15 online issue of PLOS ONE, in collaboration with Creighton University, Medical University of South Carolina and GrassrootsHealth, an Encinitas-based nonprofit organization that promotes vitamin D research and its therapeutic benefits. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

PIM-2 protein kinase regulates T-cell activity differently than PIM-1 or PIM-3 isoform
(Medical University of South Carolina) The PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity, while PIM-1 and PIM-3 are positive regulators, report Medical University of South Carolina investigators in The Journal of Clinical Investigation. Blocking PIM-2 in allogeneic bone marrow transplant dramatically accelerated graft-versus-host disease. In adoptive immunotherapy with autologous T cells, silencing PIM-2 on T cells produced robust tumor immunity, highlighting the importance of PIM-specific inhibition. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

Researchers find combination can enhance ipilimumab immunotherapy
(University of Texas M. D. Anderson Cancer Center) Using a targeted therapy to block a protein that suppresses T cell activity could improve cancer treatment with immune checkpoint inhibitors, researchers at The University of Texas MD Anderson Cancer Center report today in the Journal of Clinical Investigation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

JAK inhibitors associated with aggressive lymphoma
(American Society of Hematology) Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

NICE Rejects Adjuvant Perjeta in HER2 Breast Cancer
(MedPage Today) -- In contrast with FDA, Britain's cost watchdog says drug may not offer'meaningful'benefit (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 15, 2018 Category: American Health Source Type: news

Cut your risk for liver cancer by HALF by just increasing your vitamin D levels
(Natural News) Did you know that roughly 38.4 percent of people will be diagnosed with some type of cancer during their lifetime? If you’re “lucky,” yours might just be a harmless melanoma that your dermatologist can remove in their office. If you’re really unlucky, on the other hand, you could end up with one of... (Source: NaturalNews.com)
Source: NaturalNews.com - June 15, 2018 Category: Consumer Health News Source Type: news

Living With Cancer: Ovarian cancer vaccine
Ovarian cancer vaccine: Can it prevent recurrence? Ovarian cancer vaccines are a type of immunotherapy, which is treatment that harnesses the body's germ-fighting immune system to attack cancer cells. Researchers hope to use ovarian cancer vaccines to train the immune system cells to detect and attack any cancer cells that reappear after initial treatment has [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 15, 2018 Category: Databases & Libraries Source Type: news

Consumer Health: Men's health -- live a longer, healthier life
Men's health: Prevent the top threats? The biggest threats to men's health ? which include heart disease, cancer, unintentional injuries, chronic lower respiratory disease and stroke ??often are preventable. Take control by talking with your health care provider about your risk factors for these conditions. Then, get serious about reducing your risk. Here's what you [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 15, 2018 Category: Databases & Libraries Source Type: news

Strategies to Avoid Sunburn
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

Liver Cancer a Big Threat to U.S., Other Developed Nations
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - June 15, 2018 Category: Cancer & Oncology Source Type: news

General taxation still best way to generate NHS funds
Experts explore financial models to fund health Related items fromOnMedica Expert Panel proposes ring-fenced tax solely for NHS and social care Cancer strategies failed to improve one-year survival Health Foundation sets out reasons for more NHS investment GPs warn government: fund service properly or it will collapse NHS is failing patients with mental health problems (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 15, 2018 Category: UK Health Source Type: news

NICE rejects adjuvant use of breast cancer drug
Draft guidance dubs Perjeta ‘not cost effective’ Related items fromOnMedica NICE fast-tracks approval of new skin cancer treatment New breast cancer drug ‘unaffordable’ for NHS One in 10 children in phase I cancer trials respond to drugs Cancer strategies failed to improve one-year survival Genetic risk model could guide prostate cancer screening (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 15, 2018 Category: UK Health Source Type: news

Kids consume more than a year ’s sugar in six months
More than double recommendation consumed Related items fromOnMedica Tackling obesity ‘must be made a national priority’ UK lagging behind peers on child health We are ‘sitting on a young people’s health time bomb’ Diabetes will soon cost NHS £16.9bn Global cancer burden set to soar (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 15, 2018 Category: UK Health Source Type: news

Vitamin D: Good for bones, and possibly the colon
Vitamin D helps with bone health, but could it also help prevent colon cancer? (Source: ABC News: Health)
Source: ABC News: Health - June 14, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Nottingham beauty therapists taught to spot skin cancer signs
There are more than 2,400 deaths from melanoma every year, according to Cancer Research UK. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 14, 2018 Category: Consumer Health News Source Type: news

Should mFOLFIRINOX Be Standard of Care in Adjuvant Tx of Pancreatic Cancer?
Compared with gemcitabine, mFOLFIRINOX improved outcomes for all endpoints when used in the adjuvant setting. (Source: CancerNetwork)
Source: CancerNetwork - June 14, 2018 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news

New Role for Maintenance Chemo in Rhabdomyosarcoma?
Six months of maintenance chemotherapy improved OS in children with high-risk rhabdomyosarcoma. (Source: CancerNetwork)
Source: CancerNetwork - June 14, 2018 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news

Chemo Adverse Events More Frequent in Female Colon Cancer Patients Chemo Adverse Events More Frequent in Female Colon Cancer Patients
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

CDH Beats Varian in Bid for Embattled Sirtex
Money talked and Sirtex Medical listened. The New South Wales, Australia-based medical device company that provides a targeted internal radiation therapy for certain liver cancers, said its board decided that the competing bid from CDH Investments was superior to the earlier bid it received from Varian. In January, Palo Alto, CA-based Varian offered to pay about $1.3 billion (A$28 a share) to acquire Sirtex, and the two companies entered into an agreement, which Sirtex shareholders were expected to approve on May 7. That was until CDH, a major alternative asset management firm based in Beijing, Chi...
Source: MDDI - June 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Race May Be Factor in Completion of Neoadjuvant Breast CA Chemo Race May Be Factor in Completion of Neoadjuvant Breast CA Chemo
White women with breast cancer are more likely to complete their neoadjuvant chemotherapy regimen than women of color, a U.S. study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Higher vitamin D levels linked to lower colorectal cancer risk, study finds
Higher concentrations of vitamin D circulating in the bloodstream are linked to a lower risk of colorectal cancer, according to a large international study published Thursday.The researchers said the results strengthen the evidence that the vitamin may play a protective role against the disease,... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - June 14, 2018 Category: Science Authors: Laurie McGinley Source Type: news

Trastuzumab Biosimilar on Par With Reference Product in Early Breast Cancer Trastuzumab Biosimilar on Par With Reference Product in Early Breast Cancer
Safety, efficacy and clinical outcomes were similar for Amgen's trastuzumab biosimilar ABP 980 and the trastuzumab reference product in women with HER2-positive early breast cancer in the LILAC study, researchers reported June 4 at the 2018 ASCO Annual Meeting.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Olathe biotech moves dog cancer treatment closer to market
A Kansas City-area animal health company is ramping up its efforts to take its cancer immunotherapy treatment to market. Elias Animal Health, a subsidiary of Olathe-based TVAX Biomedical Inc., applied for a conditional licensure of its treatment for dogs with bone cancer through the U.S. Department of Agriculture’s Center for Veterinary Biologics. Elias recently completed preliminary studies of its osteosarcoma treatment and will enroll for a pivotal study as the next step. On Thursday, the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 14, 2018 Category: American Health Authors: Elise Reuter Source Type: news

Omega-3 Fatty Acids Reduce Pain From AIs at BMI of 30 or More Omega-3 Fatty Acids Reduce Pain From AIs at BMI of 30 or More
Omega-3 fatty acids significantly reduced pain among very overweight women who take aromatase inhibitors (AIs) for breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Have a large waistline? You most likely have a vitamin D deficiency, according to this study
(Natural News) If you’re overweight, there are plenty of things you might worry about, from looking good in your clothes and brushing off cruel comments, to avoiding the serious health problems associated with your weight, like diabetes and cancer. However, a new study points to an often-overlooked issue facing many obese people that can have... (Source: NaturalNews.com)
Source: NaturalNews.com - June 14, 2018 Category: Consumer Health News Source Type: news

Does Vitamin D Really Protect Against Colorectal Cancer?
(Source: NPR Health and Science)
Source: NPR Health and Science - June 14, 2018 Category: Consumer Health News Authors: Patti Neighmond Source Type: news

Public Health Grand Rounds: Prevention and Control of Skin Cancer
Originally presented on Tuesday, April 21, 2015. Encore presentation scheduled for Tuesday, June 19, 2018, at 1:00 PM ET. (Source: PHPartners.org)
Source: PHPartners.org - June 14, 2018 Category: International Medicine & Public Health Source Type: news

OncoBreak: HPV Vax and Cancer; Machine Spots Lymphedema; Risky Gene Editing
(MedPage Today) -- News, features, and commentary about cancer-related issues (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 14, 2018 Category: American Health Source Type: news

More Cincinnati doctors sign on to recommend medical marijuana
Ohio ’s State Medical Board on Wednesday approved more physicians for certificates to recommend medical marijuana to their patients. Among the names newly added to the list are 15 doctors in Greater Cincinnati. Doctors with the certification may recommend – not “prescribe” – marijuana for pati ents diagnosed with 21 approved conditions such as cancer and chronic severe pain.  The local physicians that have been added to the list are: James Bingham, Cincinnati Shayla Pullen, Cincinnati Zeeshan… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 14, 2018 Category: Health Management Authors: Erin Caproni Source Type: news

Back pain - this is how to tell if your lower backache is a sign of cancer
BACK pain - particularly pain in the lower back - is a common problem that affects most people at some point in their life. Lower back pain could be a sign of cancer, patients have been warned. These are the symptoms of a spinal tumour to look out for - is your back pain a sign of something serious? (Source: Daily Express - Health)
Source: Daily Express - Health - June 14, 2018 Category: Consumer Health News Source Type: news

People want cancer screening, despite pitfalls
A new study found that individuals had a strong preference for cancer screening...Read more on AuntMinnie.comRelated Reading: Are we using the right metrics for CT lung screening? Faster MRI protocol avoids unneeded prostate biopsies Mammography compliance leads to other screening tests Breast cancer survivors don't get regular mammograms Cancer death rates continue to decline in U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 14, 2018 Category: Radiology Source Type: news

Higher vitamin D levels cut colorectal cancer risk by 31%
The report, led by the Harvard, adds weight to a theory which had not been proven. Three quarters of Americans and a fifth of Brits are vitamin D deficient, and colorectal cancer rates are rising. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2018 Category: Consumer Health News Source Type: news

Higher vitamin D levels cut colorectal cancer risk by 31%, major international study finds
The report, led by the Harvard, adds weight to a theory which had not been proven. Three quarters of Americans and a fifth of Brits are vitamin D deficient, and colorectal cancer rates are rising. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2018 Category: Consumer Health News Source Type: news

Results of Novel Mesothelioma Drug Presented at ASCO Meeting
A multicenter phase II clinical trial involving the latest orally administered protein inhibitor drug has shown considerable promise in helping control malignant mesothelioma. The effectiveness of tazemetostat was presented last week at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. The trial study, which will conclude late 2018, involves 74 previously treated patients with recurring mesothelioma. “We’ve seen benefit for some patients with this treatment and patients who have benefited over a long period of time,” medical oncologist Dr. Marianna Koczywas, City of Hope Cancer T...
Source: Asbestos and Mesothelioma News - June 14, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

How to live longer: Dr Hilary Jones reveals the key to longevity is this diet
HOW TO live longer is question many people want to know the answer to as they get older. Quitting smoking can slash your risk of dying from cancer and stroke, but what should you be including in your diet to improve your life expectancy? (Source: Daily Express - Health)
Source: Daily Express - Health - June 14, 2018 Category: Consumer Health News Source Type: news

Apexigen and Yale Cancer Center Announce Clinical Collaboration to Evaluate APX005M, Cabiralizumab, and Opdivo (Nivolumab) in Patients whose Disease has Progressed on Anti-PD-1/PD-L1 Therapy
Phase 1/2 clinical trial in patients with advanced solid tumors that have progressed on anti-PD-1/PD-L1 therapy to evaluate APX005M in combination with cabiralizumab and Opdivo Study to enroll metastatic non-small cell lung cancer (NSCLC), metastatic me... Biopharmaceuticals, Oncology Apexigen, cabiralizumab, Opdivo, NSCLC, melanoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2018 Category: Pharmaceuticals Source Type: news

Namibia:Mickey Mouse Brightens Day for Young Cancer Patients
[Namibia Economist] Children in the cancer ward of the Windhoek Central Hospital were delighted last week when Micky Mouse and his consort, Minnie, visited them for a day full of fun and unexpected gifts. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 14, 2018 Category: African Health Source Type: news

Scientists WARN: Genetic editing of humans with "CRISPR" technology may lead to generation of cancer sufferers
(Natural News) CRISPR-Cas9 is a budding technology, with proponents singing its praises for the last few years. But it turns out this “promising” advancement comes with some unintended side effects – like the potential to cause cancer in a whole generation of humans (if not more). It appears the more we learn about CRISPR, the... (Source: NaturalNews.com)
Source: NaturalNews.com - June 14, 2018 Category: Consumer Health News Source Type: news

Uganda:Cancer Institute 'Resumes' Radiotherapy Services
[Observer] Radiotherapy services at the Uganda Cancer Institute (UCI) have fully resumed following the completion of the servicing of the Cobalt 60 Radiotherapy machine. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 14, 2018 Category: African Health Source Type: news

Fewer side-effects and similar benefits from shorter chemotherapy after bowel cancer surgery
This expert commentary is provided for an RCT which found a similar three year progression free survival for 3 months and 6 months of chemotherapy. Most guidelines recommend six months treatment, this study gives the potential to improve acceptability and uptake of treatment (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 14, 2018 Category: Consumer Health News Source Type: news

Single routine offer of a blood test for prostate cancer did not save lives
Expert commentary is provided for a study which found no difference in rates of prostate cancer death for screening vs no screening. Screening may increase diagnoses but does not reduce deaths. Trials like this one challenge “advances” that appear common sense but may do harm. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 14, 2018 Category: Consumer Health News Source Type: news